Old Web
English
Sign In
Acemap
>
authorDetail
>
Isabelle Lepage-Nefkens
Isabelle Lepage-Nefkens
Biosimilar
Actuarial science
Alternative medicine
Biosimilar Pharmaceuticals
Authorization
5
Papers
61
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Is Procalcitonin Biomarker-Guided Antibiotic Therapy a Cost-Effective Approach to Reduce Antibiotic Resistant and Clostridium difficile Infections in Hospitalized Patients?
2018
Omics A Journal of Integrative Biology
Lotte Maria Gertruda Steuten
J.C. Mewes
Isabelle Lepage-Nefkens
H.J.M. Vrijhoef
Show All
Source
Cite
Save
Citations (2)
Horizon Scanning for Pharmaceuticals: proposal for the BeNeLuxA collaboration
2017
Isabelle Lepage-Nefkens
Karla Douw
Gertjan Mantjes
Gimon de Graaf
Roos Leroy
Irina Cleemput
Show All
Source
Cite
Save
Citations (7)
Management and performance features of cancer centers in Europe: A fuzzy-set analysis
2016
Journal of Business Research
Anke Wind
Mf Lobo
Joris van Dijk
Isabelle Lepage-Nefkens
Jose Laranja Pontes
Vítor da Conceição Gonçalves
Willem H. van Harten
Francisco Rocha-Gonçalves
Show All
Source
Cite
Save
Citations (2)
Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?
2014
European Journal of Health Economics
Maria Isabel Farfan-Portet
Sophie Gerkens
Isabelle Lepage-Nefkens
Irmgard Vinck
Frank Hulstaert
Show All
Source
Cite
Save
Citations (49)
BARRIERS AND OPPORTUNITIES FOR THE UPTAK BIOSIMILAR MEDICINES IN BELGIUM
2013
Isabelle Lepage-Nefkens
Sophie Gerkens
Frank Hulstaert
María Isa
Show All
Source
Cite
Save
Citations (1)
1